Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.

MLA

van la Parra, R. F. D., et al. “Validation of a Nomogram to Predict the Risk of Nonsentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node Biopsy: Validation of the MSKCC Breast Nomogram.” Annals of Surgical Oncology, vol. 16, no. 5, May 2009, pp. 1128–35. EBSCOhost, https://doi.org/10.1245/s10434-009-0359-y.

APA

van la Parra, R. F. D., Ernst, M. F., Bevilacqua, J. L. B., Mol, S. J. J., Van Zee, K. J., Broekman, J. M., & Bosscha, K. (2009). Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Annals of Surgical Oncology, 16(5), 1128–1135. https://doi.org/10.1245/s10434-009-0359-y

Chicago

van la Parra, R F D, M F Ernst, J L B Bevilacqua, S J J Mol, K J Van Zee, J M Broekman, and K Bosscha. 2009. “Validation of a Nomogram to Predict the Risk of Nonsentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node Biopsy: Validation of the MSKCC Breast Nomogram.” Annals of Surgical Oncology 16 (5): 1128–35. doi:10.1245/s10434-009-0359-y.